ATP13A3-DT: A Potential Drug Target for Cardiovascular Diseases

Target Name: ATP13A3-DT

NCBI ID: G401106

Other Name(s): ATP13A3 divergent transcript | LINC00884

ATP13A3-DT: A Potential Drug Target for Cardiovascular Diseases

ATP13A3-DT is a gene that encodes a protein known as ATP13A3-DT, which is a key regulator of the ion channels in the heart. The function of ATP13A3-DT is to regulate the movement of ions into and out of the heart's cells, which is essential for maintaining normal electrical activity and heart function. Mutations in the ATP13A3-DT gene have been linked to various cardiovascular diseases, including heart failure, arrhythmias, and sudden cardiac death.

Drug Target and Biomarker

The discovery of ATP13A3-DT as a drug target and biomarker has significant implications for the treatment of cardiovascular diseases. By blocking the function of ATP13A3-DT, doctors can potentially improve heart function and reduce the risk of cardiovascular events.

One of the key advantages of targeting ATP13A3-DT is its potential to be a once-weekly therapy, as it is expressed in high levels in the heart and can be easily administered by intravenous infusions. Additionally, because it is a protein, it can be targeted directly and inhibit its function without affecting the rest of the body.

ATP13A3-DT is a transmembrane protein which means it spans the membrane of the heart's cells and is involved in the regulation of ion channels. It is composed of four subunits, each of which has a unique function in regulating the movement of ions.

The first subunit is the alpha subunit, which is responsible for the regulation of the heart's electrical activity. The alpha subunit is known to interact with several other proteins, including the B-type calcium ion channel. By interacting with these proteins, the alpha subunit helps to regulate the flow of calcium ions into the heart's cells, which is essential for muscle contractions.

The second subunit is the beta subunit, which is responsible for the regulation of the heart's electrical activity. The beta subunit is known to interact with several other proteins, including the A-type calcium ion channel. By interacting with these proteins, the beta subunit helps to regulate the flow of calcium ions into the heart's cells, which is essential for muscle contractions.

The third subunit is the gamma subunit, which is responsible for the regulation of the heart's electrical activity. The gamma subunit is known to interact with several other proteins, including the sodium ion channel. By interacting with these proteins, the gamma subunit helps to regulate the flow of sodium ions into the heart's cells, which is essential for the normal functioning of the heart's electrical activity.

The fourth subunit is the delta subunit, which is responsible for the regulation of the heart's electrical activity. The delta subunit is known to interact with several other proteins, including the potassium ion channel. By interacting with these proteins, the delta subunit helps to regulate the flow of potassium ions into the heart's cells, which is essential for the normal functioning of the heart's electrical activity.

Mutations in the ATP13A3-DT gene have been linked to various cardiovascular diseases, including heart failure, arrhythmias, and sudden cardiac death. The discovery of ATP13A3-DT as a drug target and biomarker has significant implications for the treatment of cardiovascular diseases. By blocking the function of ATP13A3-DT, doctors can potentially improve heart function and reduce the risk of cardiovascular events.

Conclusion

ATP13A3-DT is a gene that encodes a protein known as ATP13A3-DT, which is a key regulator of the ion channels in the heart. The function

Protein Name: ATP13A3 Divergent Transcript

More Common Targets